Thrombosis post-mRNA-based SARS-CoV-2 vaccination (BNT162b2) – Time to think beyond thrombosis with thrombocytopenia syndrome (TTS)
<p dir="ltr">The COVID-19 pandemic has affected the global socioeconomic and healthcare infrastructure. Vaccines have been the cornerstone in limiting the global spread of the pandemic. However, the mass scale vaccination has resulted in some unanticipated adverse events. Arguably th...
Saved in:
| Main Author: | Zohaib Yousaf (9617058) (author) |
|---|---|
| Other Authors: | Fateen Ata (12217764) (author), Riyadh Ali Mohammed Hammamy (17563143) (author) |
| Published: |
2022
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparable antibody levels in heterologous and homologous mRNA COVID-19 vaccination, with superior neutralizing and IgA antibody responses in mRNA homologous boosting
by: Salma, Younes
Published: (2024) -
Assessment of the Neutralizing Antibody Response of BNT162b2 and mRNA-1273 SARS-CoV-2 Vaccines in Naïve and Previously Infected Individuals: A Comparative Study
by: Farah M. Shurrab (16324961)
Published: (2022) -
Comparable antibody levels in heterologous and homologous mRNA COVID-19 vaccination, with superior neutralizing and IgA antibody responses in mRNA homologous boosting
by: Salma Younes (6424865)
Published: (2024) -
Acute myocarditis following administration of BNT162b2 vaccine
by: Mhd Baraa Habib (11721774)
Published: (2021) -
Syncope following Pfizer BioNTech (bnt162b2) vaccination unmasking Brugada syndrome
by: Mohammad Altermanini (16810755)
Published: (2023)